Isatuximab 500mg/25ml solution for infusion vials
NHS hospitals in England used £89,828,693 of indicative cost of Isatuximab 500mg/25ml solution for infusion vials in the 12 months to July 2026, about 0.3% of all hospital medicines spend. That is up 60.6% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Isatuximab 500mg/25ml solution for infusion vials: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Isatuximab 500mg/25ml solution for infusion vials most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Univ Hpl B/Ham Nhs Foundation Trust | £3,364,041 |
| University College London Foundation Tr | £2,562,572 |
| United Lincolnshire Hospitals Nhs Trust | £2,468,788 |
| King's College Hpl Nhs Foundation Trust | £2,438,575 |
| Norfolk & Norwich University Hpl Nhs Trt | £2,322,283 |
| Manchester University Nhs Ft | £2,248,270 |
| Hampshire Hospitals Nhs Foundation Trust | £2,167,667 |
| Derby Teaching Hospitals Nhs Found Trust | £2,110,383 |
| Western Sussex Hospitals Nhs Found Trust | £1,978,579 |
| Ruh Bath Nhs Foundation Trust | £1,898,483 |
The primary-care picture
No confident match to a community-dispensed medicine was found for this product, so no primary-care comparison is shown. SCMD products are recorded at product level, which does not always map cleanly to a BNF substance.